Companies: 10,795·Total market cap: $144.5T
Summit Therapeutics Inc.

Summit Therapeutics Inc.

SMMTNASDAQHealthcare● Active
$14.77
$-0.07(-0.47%)
Market Cap$11.5B
P/E Ratio—
52W High$30.98
52W Low$13.83
Overview

Summit Therapeutics Inc. (SMMT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001599298 · SMMT · NASDAQ · as of Jun 8, 2026

Filing snapshot

537
Total Filings
4
Latest Form
2026-06-04
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001599298 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-23
Fiscal Year End
Feb 23, 2026
Accession No.
0001599298-26-000015
Primary Document
smmt-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001599298 · Accession 0001599298-26-000015

Latest Key Filings

10-QQuarterly Report
10-Q
2026-04-30
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-03Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-03
View
8-KCurrent Report
8-K
2026-06-01
View
10-QQuarterly Report
10-Q
2026-04-30
View
8-KCurrent Report
8-K
2026-04-30
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-17
View
ARSARS
ARS
2026-04-17
View
DEF 14AProxy Statement
DEF 14A
2026-04-17
View
PRE 14APRE 14A
PRE 14A
2026-04-06
View
S-8Employee Stock Plan Registration
S-8
2026-02-23
View
10-KAnnual Report
10-K
2026-02-23
View
8-KCurrent Report
8-K
2026-02-23
View
8-KCurrent Report
8-K
2026-01-29
View
8-KCurrent Report
8-K
2026-01-12
View
8-KCurrent Report
8-K
2025-11-07
View
S-3ASRS-3ASR
S-3ASR
2025-10-29
View
Showing 1–15 of 432 filingsForm 4 / 144 hidden· 537 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001599298  |  Exchange: NASDAQ · Healthcare

Summit Therapeutics Inc. (NASDAQ: SMMT) has submitted 537 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001599298, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Summit Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Summit Therapeutics Inc. 10-K was filed on 2026-02-23 for fiscal year ending 2026. Historical SMMT 10-K annual reports are available from 2014 through 2026.

Investors researching Summit Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
RVMD SEC Filings →RPRX SEC Filings →ROIV SEC Filings →EXAS SEC Filings →MRNA SEC Filings →BBIO SEC Filings →ASND SEC Filings →IONS SEC Filings →
→ SMMT Financials→ SMMT Earnings→ SMMT Insider Trades

Frequently Asked Questions

SMMT SEC Filings · 8 questions

Summit Therapeutics Inc. (SMMT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 537 filings and access original documents at no cost. Summit Therapeutics Inc.'s CIK is 0001599298.

SMMT SEC filingsSummit Therapeutics Inc. SEC documentsfind SMMT 10-K